The global Agricultural Biotechnology market worth $ 113,947.6 million by 2030, growing at a CAGR of 9.3%

The use of biotechnological sciences is prevalent in many sectors. The agricultural biotechnology market can be categorized into two main segments: transgenic seeds and crop protection techniques. The application of biotechnology in the agricultural field helps in developing plants, animals and other living beings, by modifying them genetically, which can increase the productivity of crops (transgenic or genetically modified). It can also protect crops from destructive diseases. It is an innovative technology which has proven to be cost effective for the production of crops. With the rising population across the world, clearly there’s a requirement for more food production, which is mostly dependent on farming. There is a gap between the demand of food grains and their supply. This method of crop production results in more varieties of crops, with a higher yield, which is high in nutritional value and resistant to pests, giving a longer shelf life to the products. Some of the major crops being produced by genetic modification are soybean, corn, and potato. Apart from food consumption, this technology is also used to meet the demand for biofuels.

Key company profile in the Global Agricultural Biotechnology Market BASF SE Bayer AG, Benson Hill Inc., Certis USA LLC, Corteva, Inc.Eurofins Scientific SE, Evogene Ltd., Isagro SPA, KWS SAAT SE & Co. KGaA, Marrone Bio Innovations, Inc., Novozymes A/S, Performance Plants Inc., Syngenta AG, Syngenta AG, Monsanto, DuPont, Performance Plants Inc., Global Bio-Chem Technology Group, and ADAMA Agricultural Solutions..

Major investments are being made towards the research and development of genetically modified crops because they are healthier and their by-products can be used for other purposes as well. The food production sector is one of the largest industries, and the agricultural biotechnology market has started playing a major role in it, by introducing new technologies, which offer more to the consumer, and are environment friendly at the same time. However, this technology is not accepted in some places, due to opposition by consumers and strict government laws against their usage.

North America dominated the production of genetically modified crops in 2015. There is more awareness and acceptance of this kind of crop production in American countries, along with supportive governmental laws and regulations. Major production companies are based in this region, which are heavily investing in the research and development of agricultural biotechnology. North America is expected to maintain its dominance throughout the forecast period and drive this market towards further growth. The Asia Pacific region is also witnessing a tremendous growth in the agricultural biotechnology market due to its rising population, and the demand for food and biotechnology based products. This region is rapidly adapting modern techniques for farming. Genetically modified golden, pest resistant biotech wheat, and insect resistant biotech mustard are some of the crops that are being mass produced for consumption in this region. However, the European market is hesitant to the production of genetically modified crops. The European Union has developed and implemented a complex policy framework, since the 1990s, which has slowed down and limited the research and development of genetically modified crops. These regulations are likely to hinder the growth of the global agricultural biotechnology market in this region.

Syngenta AG, Monsanto, DuPont, Performance Plants Inc., Global Bio-Chem Technology Group, and ADAMA Agricultural Solutions are some of the key players in this industry.

Agricultural Biotechnology Market Scope

Key segments of the Global Agricultural Biotechnology Market

Technology, (USD Million)

• Genome Editing
• Deoxyribonucleic Acid Sequencing
• Ribonucleic Acid Interference
• Biochip

Based on Product, (USD Million)

• Transgenic Seeds
• Soybean
• Maize
• Cotton
• vegetables

Application, (USD Million)

• Vaccine Development
• Transgenic Crops & Animals
• Antibiotic Development
• Nutritional Supplements
• Flower Culturing
• Biofuels

Region Overview, (USD Million)

• North America
  • United States of America
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • the Netherlands
  • Poland
  • Russia
  • The United Kingdom
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Indonesia
  • South Korea
  • Rest of Asia-Pacific
• South America
  • Argentina
  • Brazil
  • Peru
  • Uruguay
  • Rest of South America